BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 12014007)

  • 1. [Mitochondrial acyl-CoA dehydrogenases (VLCAD, LCAD, MCAD, SCAD)].
    Yamaguchi S
    Nihon Rinsho; 2002 Apr; 60 Suppl 4():94-7. PubMed ID: 12014007
    [No Abstract]   [Full Text] [Related]  

  • 2. Synergistic heterozygosity in mice with inherited enzyme deficiencies of mitochondrial fatty acid beta-oxidation.
    Schuler AM; Gower BA; Matern D; Rinaldo P; Vockley J; Wood PA
    Mol Genet Metab; 2005 May; 85(1):7-11. PubMed ID: 15862275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mitochondrial 3-hydroxyacyl-CoA dehydrogenase (SCHAD, LCHAD)].
    Yamaguchi S
    Nihon Rinsho; 2002 Apr; 60 Suppl 4():101-4. PubMed ID: 12013827
    [No Abstract]   [Full Text] [Related]  

  • 4. [Mitochondrial 3-ketoacyl-CoA thiolase].
    Yamaguchi S; Kanai R
    Nihon Rinsho; 2002 Apr; 60 Suppl 4():105-8. PubMed ID: 12013828
    [No Abstract]   [Full Text] [Related]  

  • 5. Mutation analysis in mitochondrial fatty acid oxidation defects: Exemplified by acyl-CoA dehydrogenase deficiencies, with special focus on genotype-phenotype relationship.
    Gregersen N; Andresen BS; Corydon MJ; Corydon TJ; Olsen RK; Bolund L; Bross P
    Hum Mutat; 2001 Sep; 18(3):169-89. PubMed ID: 11524729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mitochondrial enoyl-CoA hydratase].
    Yamaguchi S
    Nihon Rinsho; 2002 Apr; 60 Suppl 4():98-100. PubMed ID: 12014008
    [No Abstract]   [Full Text] [Related]  

  • 7. New genetic defects in mitochondrial fatty acid oxidation and carnitine deficiency.
    Stanley CA
    Adv Pediatr; 1987; 34():59-88. PubMed ID: 3318304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of dietary fatty acid chain-length on metabolic tolerance in mouse models of inherited defects in mitochondrial fatty acid beta-oxidation.
    Schuler AM; Gower BA; Matern D; Rinaldo P; Wood PA
    Mol Genet Metab; 2004 Dec; 83(4):322-9. PubMed ID: 15589119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prenatal diagnosis of mitochondrial fatty acid oxidation defects.
    Nada MA; Vianey-Saban C; Roe CR; Ding JH; Mathieu M; Wappner RS; Bialer MG; McGlynn JA; Mandon G
    Prenat Diagn; 1996 Feb; 16(2):117-24. PubMed ID: 8650121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purification of human very-long-chain acyl-coenzyme A dehydrogenase and characterization of its deficiency in seven patients.
    Aoyama T; Souri M; Ushikubo S; Kamijo T; Yamaguchi S; Kelley RI; Rhead WJ; Uetake K; Tanaka K; Hashimoto T
    J Clin Invest; 1995 Jun; 95(6):2465-73. PubMed ID: 7769092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural basis for substrate fatty acyl chain specificity: crystal structure of human very-long-chain acyl-CoA dehydrogenase.
    McAndrew RP; Wang Y; Mohsen AW; He M; Vockley J; Kim JJ
    J Biol Chem; 2008 Apr; 283(14):9435-43. PubMed ID: 18227065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel disease with deficiency of mitochondrial very-long-chain acyl-CoA dehydrogenase.
    Aoyama T; Uchida Y; Kelley RI; Marble M; Hofman K; Tonsgard JH; Rhead WJ; Hashimoto T
    Biochem Biophys Res Commun; 1993 Mar; 191(3):1369-72. PubMed ID: 8466512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-chain acyl-CoA dehydrogenase is a key enzyme in the mitochondrial beta-oxidation of unsaturated fatty acids.
    Lea W; Abbas AS; Sprecher H; Vockley J; Schulz H
    Biochim Biophys Acta; 2000 May; 1485(2-3):121-8. PubMed ID: 10832093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative analysis of urinary acylglycines for the diagnosis of beta-oxidation defects using GC-NCI-MS.
    Costa CG; Guérand WS; Struys EA; Holwerda U; ten Brink HJ; Tavares de Almeida I; Duran M; Jakobs C
    J Pharm Biomed Anal; 2000 Jan; 21(6):1215-24. PubMed ID: 10708405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case of impairment of mitochondrial fatty acid beta-oxidation.
    Hasegawa T; Hori N; Du W
    Keio J Med; 2002 Jun; 51(2):100-6. PubMed ID: 12125906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disorders of mitochondrial fatty acyl-CoA beta-oxidation.
    Wanders RJ; Vreken P; den Boer ME; Wijburg FA; van Gennip AH; IJlst L
    J Inherit Metab Dis; 1999 Jun; 22(4):442-87. PubMed ID: 10407780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of heat stress and bezafibrate on mitochondrial beta-oxidation: comparison between cultured cells from normal and mitochondrial fatty acid oxidation disorder children using in vitro probe acylcarnitine profiling assay.
    Li H; Fukuda S; Hasegawa Y; Kobayashi H; Purevsuren J; Mushimoto Y; Yamaguchi S
    Brain Dev; 2010 May; 32(5):362-70. PubMed ID: 19589653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Encephalomyopathy due to a beta oxidation deficiency. Report of a new case].
    Balestri P; Mostardini R
    Minerva Pediatr; 1991 Mar; 43(3):93-5. PubMed ID: 1870532
    [No Abstract]   [Full Text] [Related]  

  • 19. Is autism a disorder of fatty acid metabolism? Possible dysfunction of mitochondrial beta-oxidation by long chain acyl-CoA dehydrogenase.
    Clark-Taylor T; Clark-Taylor BE
    Med Hypotheses; 2004; 62(6):970-5. PubMed ID: 15142659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The reductive half reaction in the acyl-CoA dehydrogenases.
    Thorpe C
    Prog Clin Biol Res; 1990; 321():91-105. PubMed ID: 2183245
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.